Summarizing our results, the oxidative stress is clearly an evidence in MS patients, but while the values of TAS and dROMs appeared not to be influenced by therapy, underlining the general systemic oxidative stress in MS, Cp:Tf ratio is a good index to detect oxidative stress strictly related to Fe and potentially related with therapy. The gene discussed is CP; the disease is myeloid sarcoma.